Huang K, He Y, Wan H, Ban X, Chen X, Hu X
Front Immunol. 2024; 15:1437570.
PMID: 39474417
PMC: 11518718.
DOI: 10.3389/fimmu.2024.1437570.
Preedy M, White M, Tergaonkar V
Cell Death Dis. 2024; 15(3):202.
PMID: 38467621
PMC: 10928192.
DOI: 10.1038/s41419-024-06559-z.
Collie G, Clark M, Keefe A, Madin A, Read J, Rivers E
J Med Chem. 2024; 67(2):864-884.
PMID: 38197367
PMC: 10823476.
DOI: 10.1021/acs.jmedchem.3c01861.
Nelson Z, Leonard G, Fehl C
J Biol Chem. 2023; 300(2):105615.
PMID: 38159850
PMC: 10831167.
DOI: 10.1016/j.jbc.2023.105615.
Hwang S, Jang H, Kojour M, Yun K, Lee Y, Han Y
Sci Rep. 2023; 13(1):18914.
PMID: 37919359
PMC: 10622451.
DOI: 10.1038/s41598-023-45978-4.
Induction of pro-inflammatory genes by fibronectin DAMPs in three fibroblast cell lines: Role of TAK1 and MAP kinases.
Maddali P, Ambesi A, McKeown-Longo P
PLoS One. 2023; 18(5):e0286390.
PMID: 37228128
PMC: 10212165.
DOI: 10.1371/journal.pone.0286390.
Notoginsenoside R1 protects against myocardial ischemia/reperfusion injury in mice via suppressing TAK1-JNK/p38 signaling.
Zeng J, Shi H, Ren F, Zhao X, Chen Q, Wang D
Acta Pharmacol Sin. 2023; 44(7):1366-1379.
PMID: 36721009
PMC: 10310839.
DOI: 10.1038/s41401-023-01057-y.
The MAP3K7 gene: Further delineation of clinical characteristics and genotype/phenotype correlations.
van Woerden G, Senden R, de Konink C, Trezza R, Baban A, Bassetti J
Hum Mutat. 2022; 43(10):1377-1395.
PMID: 35730652
PMC: 9544731.
DOI: 10.1002/humu.24425.
Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy.
Roy A, Kumar A
Nat Commun. 2022; 13(1):2201.
PMID: 35459245
PMC: 9033787.
DOI: 10.1038/s41467-022-29752-0.
TAB2 deficiency induces dilated cardiomyopathy by promoting RIPK1-dependent apoptosis and necroptosis.
Yin H, Guo X, Chen Y, Zeng Y, Mo X, Hong S
J Clin Invest. 2022; 132(4).
PMID: 34990405
PMC: 8843707.
DOI: 10.1172/JCI152297.
YEATS2 regulates the activation of TAK1/NF-κB pathway and is critical for pancreatic ductal adenocarcinoma cell survival.
Sheng H, Zheng F, Lan T, Chen H, Xu C, Wang S
Cell Biol Toxicol. 2021; 39(3):1-16.
PMID: 34686948
DOI: 10.1007/s10565-021-09671-4.
Antioxidant and Anti-Inflammatory Effects of (Blume) Leaf Methanol Extracts through the Regulation of Nrf2 and TAK1.
Lee S, Ha J, Park J, Kang E, Jeon S, Han S
Antioxidants (Basel). 2021; 10(8).
PMID: 34439543
PMC: 8389227.
DOI: 10.3390/antiox10081295.
LncRNA PCIR Is an Oncogenic Driver Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer.
Guo W, Li J, Huang H, Fu F, Lin Y, Wang C
Front Oncol. 2021; 11:630300.
PMID: 34012913
PMC: 8128249.
DOI: 10.3389/fonc.2021.630300.
TAK1-TABs Complex: A Central Signalosome in Inflammatory Responses.
Xu Y, Lei C
Front Immunol. 2021; 11:608976.
PMID: 33469458
PMC: 7813674.
DOI: 10.3389/fimmu.2020.608976.
A Synthetic Peptide, CK2.3, Inhibits RANKL-Induced Osteoclastogenesis through BMPRIa and ERK Signaling Pathway.
Nguyen J, Kelly S, Wood R, Heubel B, Nohe A
J Dev Biol. 2020; 8(3).
PMID: 32660129
PMC: 7557985.
DOI: 10.3390/jdb8030012.
Inhibition of TGFβ-activated protein kinase 1 ameliorates myocardial ischaemia/reperfusion injury via endoplasmic reticulum stress suppression.
Zeng J, Jin Q, Ruan Y, Sun C, Xu G, Chu M
J Cell Mol Med. 2020; 24(12):6846-6859.
PMID: 32378287
PMC: 7299680.
DOI: 10.1111/jcmm.15340.
Multifaceted roles of TAK1 signaling in cancer.
Mukhopadhyay H, Lee N
Oncogene. 2019; 39(7):1402-1413.
PMID: 31695153
PMC: 7023988.
DOI: 10.1038/s41388-019-1088-8.
SIRT7 Regulates Lipopolysaccharide-Induced Inflammatory Injury by Suppressing the NF-B Signaling Pathway.
Chen K, Li L, Li C, Wang Y, Yang F, Kuang M
Oxid Med Cell Longev. 2019; 2019:3187972.
PMID: 31285783
PMC: 6594283.
DOI: 10.1155/2019/3187972.
The combination of knockdown and TNFα causes synthetic lethality via caspase-8 activation in human carcinoma cell lines.
Serebrennikova O, Paraskevopoulou M, Aguado-Fraile E, Taraslia V, Ren W, Thapa G
Proc Natl Acad Sci U S A. 2019; 116(28):14039-14048.
PMID: 31239343
PMC: 6628646.
DOI: 10.1073/pnas.1901465116.
TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance.
Tripathi V, Shin J, Stuelten C, Zhang Y
Oncogene. 2019; 38(17):3185-3200.
PMID: 30626936
PMC: 6486402.
DOI: 10.1038/s41388-018-0655-8.